Insulet Net Profit Margin 2010-2025 | PODD
Current and historical net profit margin for Insulet (PODD) from 2010 to 2025. Net profit margin can be defined as net Income as a portion of total sales revenue. Insulet net profit margin for the three months ending March 31, 2025 was .
| Insulet Net Profit Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM Net Income | Net Margin |
| 2025-03-31 | $2.20B | $0.40B | 18.32% |
| 2024-12-31 | $2.07B | $0.42B | 20.26% |
| 2024-09-30 | $1.99B | $0.42B | 21.26% |
| 2024-06-30 | $1.87B | $0.40B | 21.13% |
| 2024-03-31 | $1.78B | $0.23B | 13.13% |
| 2023-12-31 | $1.70B | $0.21B | 12.13% |
| 2023-09-30 | $1.56B | $0.12B | 7.70% |
| 2023-06-30 | $1.47B | $0.06B | 4.30% |
| 2023-03-31 | $1.37B | $0.00B | 0.07% |
| 2022-12-31 | $1.31B | $0.00B | 0.38% |
| 2022-09-30 | $1.24B | $0.02B | 1.37% |
| 2022-06-30 | $1.18B | $0.04B | 2.97% |
| 2022-03-31 | $1.14B | $0.05B | 3.94% |
| 2021-12-31 | $1.10B | $0.02B | 1.55% |
| 2021-09-30 | $1.04B | $-0.03B | -2.80% |
| 2021-06-30 | $1.00B | $-0.03B | -3.02% |
| 2021-03-31 | $0.96B | $0.01B | 0.94% |
| 2020-12-31 | $0.90B | $0.01B | 0.77% |
| 2020-09-30 | $0.87B | $0.03B | 3.34% |
| 2020-06-30 | $0.83B | $0.02B | 2.18% |
| 2020-03-31 | $0.78B | $0.01B | 0.64% |
| 2019-12-31 | $0.74B | $0.01B | 1.49% |
| 2019-09-30 | $0.69B | $0.02B | 2.31% |
| 2019-06-30 | $0.65B | $0.02B | 2.60% |
| 2019-03-31 | $0.60B | $0.01B | 2.33% |
| 2018-12-31 | $0.56B | $0.00B | 0.53% |
| 2018-09-30 | $0.53B | $-0.01B | -2.64% |
| 2018-06-30 | $0.50B | $-0.02B | -3.59% |
| 2018-03-31 | $0.49B | $-0.02B | -4.93% |
| 2017-12-31 | $0.47B | $-0.03B | -5.81% |
| 2017-09-30 | $0.44B | $-0.03B | -6.62% |
| 2017-06-30 | $0.41B | $-0.03B | -7.30% |
| 2017-03-31 | $0.39B | $-0.03B | -6.70% |
| 2016-12-31 | $0.37B | $-0.03B | -7.63% |
| 2016-09-30 | $0.35B | $-0.05B | -13.26% |
| 2016-06-30 | $0.32B | $-0.06B | -19.20% |
| 2016-03-31 | $0.30B | $-0.07B | -24.58% |
| 2015-12-31 | $0.26B | $-0.07B | -27.65% |
| 2015-09-30 | $0.20B | $-0.05B | -26.15% |
| 2015-06-30 | $0.20B | $-0.04B | -21.61% |
| 2015-03-31 | $0.21B | $-0.06B | -27.14% |
| 2014-12-31 | $0.23B | $-0.05B | -22.08% |
| 2014-09-30 | $0.29B | $-0.05B | -17.19% |
| 2014-06-30 | $0.27B | $-0.06B | -21.77% |
| 2014-03-31 | $0.26B | $-0.04B | -15.83% |
| 2013-12-31 | $0.25B | $-0.05B | -18.62% |
| 2013-09-30 | $0.24B | $-0.05B | -22.46% |
| 2013-06-30 | $0.23B | $-0.04B | -19.13% |
| 2013-03-31 | $0.22B | $-0.05B | -21.27% |
| 2012-12-31 | $0.21B | $-0.05B | -24.06% |
| 2012-09-30 | $0.20B | $-0.06B | -27.36% |
| 2012-06-30 | $0.19B | $-0.06B | -29.84% |
| 2012-03-31 | $0.17B | $-0.05B | -29.65% |
| 2011-12-31 | $0.15B | $-0.05B | -30.26% |
| 2011-09-30 | $0.13B | $-0.05B | -39.85% |
| 2011-06-30 | $0.11B | $-0.05B | -45.13% |
| 2011-03-31 | $0.10B | $-0.06B | -54.81% |
| 2010-12-31 | $0.10B | $-0.06B | -62.89% |
| 2010-09-30 | $0.09B | $-0.06B | -62.92% |
| 2010-06-30 | $0.08B | $-0.06B | -73.49% |
| 2010-03-31 | $0.08B | $-0.07B | -89.33% |
| 2009-12-31 | $0.07B | $-0.07B | -110.61% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $20.550B | $2.072B |
| Insulet Corporation is a leading developer, manufacturer and marketer of the Omnipod Insulin Management System. The system is equipped with a self-adhesive, small and lightweight disposable tubeless Omnipod device along with the wireless and handheld Personal Diabetes Manager (PDM). The Omnipod System is an innovative, discreet and easy-to-use continuous insulin delivery system for people with insulin-dependent diabetes. The Omnipod System consists of Omnipod Insulin Management System ('Omnipod') and the Omnipod DASH Insulin Management System - Insulet's next generation digital mobile Omnipod platform. Insulet has tied up with pharmaceutical and biotechnological companies using customized form of the Omnipod System to deliver a drug at a certain administered volume and over a specified period of time. Insulet has partnered with pharmaceutical and biotechnology companies to tailor the Omnipod System technology platform for the delivery of subcutaneous drugs across other therapeutic areas. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $229.711B | 27.62 |
| Boston Scientific (BSX) | United States | $154.351B | 38.64 |
| Stryker (SYK) | United States | $149.416B | 31.24 |
| EssilorLuxottica (ESLOY) | France | $132.057B | 0.00 |
| Medtronic (MDT) | Ireland | $115.083B | 16.32 |
| Lonza Group Ag (LZAGY) | Switzerland | $49.624B | 0.00 |
| Haleon (HLN) | United Kingdom | $44.474B | 25.39 |
| ResMed (RMD) | United States | $37.259B | 27.99 |
| Agilent Technologies (A) | United States | $34.110B | 22.24 |
| GE HealthCare Technologies (GEHC) | United States | $34.090B | 16.18 |
| Terumo (TRUMY) | Japan | $24.459B | 31.77 |
| Koninklijke Philips (PHG) | Netherlands | $23.149B | 16.24 |
| Zimmer Biomet Holdings (ZBH) | United States | $18.570B | 11.93 |
| Baxter (BAX) | United States | $14.641B | 10.93 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $13.157B | 0.00 |
| Demant (WILYY) | Denmark | $8.633B | 0.00 |
| Sunny Optical Technology (SNPTF) | China | $8.561B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $6.825B | 23.75 |
| Lantheus Holdings (LNTH) | United States | $5.747B | 14.50 |
| Prestige Consumer Healthcare (PBH) | United States | $3.776B | 16.87 |
| Perrigo (PRGO) | Ireland | $3.768B | 9.55 |
| Haemonetics (HAE) | United States | $3.683B | 16.77 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $3.459B | 0.00 |
| Envista Holdings (NVST) | United States | $3.395B | 28.21 |
| ICU Medical (ICUI) | United States | $3.220B | 23.75 |
| QuidelOrtho (QDEL) | United States | $1.952B | 13.42 |
| LeMaitre Vascular (LMAT) | United States | $1.900B | 42.47 |
| AtriCure (ATRC) | United States | $1.550B | 0.00 |
| Acuren (TIC) | United States | $1.455B | 0.00 |
| Green Thumb Industries (GTBIF) | United States | $1.374B | 30.91 |
| Phibro Animal Health (PAHC) | United States | $1.278B | 16.34 |
| AdaptHealth (AHCO) | United States | $1.237B | 12.56 |
| Neogen (NEOG) | United States | $1.133B | 14.50 |
| BioLife Solutions (BLFS) | United States | $1.053B | 0.00 |
| InMode (INMD) | Israel | $0.932B | 9.39 |
| Kestra Medical Technologies (KMTS) | United States | $0.792B | 0.00 |
| Curaleaf Holdings (CURLF) | Canada | $0.749B | 0.00 |
| Maravai LifeSciences Holdings (MRVI) | United States | $0.680B | 0.00 |
| Tilray Brands (TLRY) | Canada | $0.661B | 0.00 |
| Owens & Minor (OMI) | United States | $0.616B | 5.11 |
| Evolus (EOLS) | United States | $0.613B | 0.00 |
| CeriBell (CBLL) | United States | $0.592B | 0.00 |
| Valneva SE (VALN) | France | $0.517B | 0.00 |
| Surmodics (SRDX) | United States | $0.449B | 0.00 |
| SNDL (SNDL) | Canada | $0.415B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.337B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.327B | 12.02 |
| Sanuwave Health (SNWV) | United States | $0.310B | 0.00 |
| Cresco Labs (CRLBF) | United States | $0.306B | 0.00 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.304B | 0.00 |
| Quanterix (QTRX) | United States | $0.302B | 0.00 |
| Cerus (CERS) | United States | $0.277B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.266B | 22.40 |
| Aurora Cannabis (ACB) | Canada | $0.257B | 76.33 |
| Sanara MedTech (SMTI) | United States | $0.257B | 0.00 |
| ZimVie (ZIMV) | United States | $0.249B | 11.30 |
| Brainsway (BWAY) | Israel | $0.231B | 61.17 |
| Omeros (OMER) | United States | $0.230B | 0.00 |
| OraSure Technologies (OSUR) | United States | $0.230B | 0.00 |
| Verano Holdings (VRNOF) | United States | $0.226B | 0.00 |
| Biote (BTMD) | United States | $0.221B | 6.22 |
| Canopy Growth (CGC) | Canada | $0.215B | 0.00 |
| Organigram Global (OGI) | Canada | $0.198B | 0.00 |
| High Tide (HITI) | Canada | $0.195B | 0.00 |
| TriSalus Life Sciences (TLSI) | United States | $0.188B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.184B | 15.00 |
| Vireo Growth (VREOF) | United States | $0.162B | 0.00 |
| Exagen (XGN) | United States | $0.151B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.123B | 15.13 |
| TerrAscend (TSNDF) | Canada | $0.115B | 0.00 |
| Fonar (FONR) | United States | $0.101B | 13.05 |
| MacroGenics (MGNX) | United States | $0.100B | 0.00 |
| Jin Medical (ZJYL) | China | $0.094B | 0.00 |
| Jushi Holdings (JUSHF) | United States | $0.092B | 0.00 |
| Veru (VERU) | United States | $0.089B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.087B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.083B | 0.00 |
| Apyx Medical (APYX) | United States | $0.074B | 0.00 |
| InterCure (INCR) | Israel | $0.071B | 0.00 |
| Agape ATP (ATPC) | $0.069B | 0.00 | |
| Cytosorbents (CTSO) | United States | $0.066B | 0.00 |
| Zynex (ZYXI) | United States | $0.064B | 0.00 |
| ImmuCell (ICCC) | United States | $0.059B | 0.00 |
| Nephros (NEPH) | United States | $0.040B | 54.00 |
| Safety Shot (SHOT) | United States | $0.040B | 0.00 |
| Modular Medical (MODD) | United States | $0.039B | 0.00 |
| Rockwell Medical (RMTI) | United States | $0.038B | 0.00 |
| United-Guardian (UG) | United States | $0.037B | 12.87 |
| Allurion Technologies (ALUR) | United States | $0.021B | 0.00 |
| Flora Growth (FLGC) | United States | $0.016B | 0.00 |
| INLIF (INLF) | $0.015B | 0.00 | |
| Meihua Medical Technologies (MHUA) | China | $0.014B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.013B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.013B | 0.00 |
| Senestech (SNES) | United States | $0.011B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.009B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.007B | 0.00 |
| Sharps Technology (STSS) | United States | $0.006B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.003B | 0.00 |
| Akanda (AKAN) | Canada | $0.002B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |